Serum and urine interferon-inducible protein 10, galectin-9, and SIGLEC-1 as biomarkers of disease activity in systemic lupus erythematosus
Turkish Journal of Medical Sciences · 03.04.2024 · 54 (2) · 391-400
DOI: 10.55730/1300-0144.5804 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 03.04.2024. Verfasst von Şafak Mirioğlu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, İstanbul Faculty of Medicine, İstanbul University, Turkiye. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Biomarkers, Galectins, Chemokine CXCL10. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background/aim: In this prospective study, we aimed to investigate the association of serum (s) and urine (u) IP-10, galectin-9, and SIGLEC-1 with disease activity in patients with systemic lupus erythematosus (SLE).Materials and methods: Sixty-three patients with active SLE (31 renal, 32 extrarenal) were included. Thirty patients with inactive SLE (15 renal, 15 extrarenal), 17 with renal active AAV, and 32 healthy volunteers were selected as control groups. Serum and urine IP-10, galectin-9, and SIGLEC-1 were tested using ELISA.Results: Levels of sIP-10 (p = 0.046), uIP-10 (p < 0.001), sGalectin-9 (p = 0.03), and uSIGLEC-1 (p = 0.006) were significantly higher in active SLE group compared to the inactive SLE; however, no differences were detected in the comparison of uGalectin-9 (p = 0.18) and sSIGLEC-1 (p = 0.69) between two groups. None of the biomarkers discriminated patients with active renal SLE from active extrarenal SLE. ROC analyses revealed an AUC of 0.63 (0.52–0.73) for sIP-10, 0.78 (0.68–0.86) for uIP-10, 0.64 (0.53–0.74) for sGalectin-9, and 0.68 (0.57–0.77) for uSIGLEC-1 in discriminating disease activity in SLE, which did not outperform C3 (0.75, 0.64–0.84) and C4 (0.72, 0.61–0.82). sIP-10 (p = 0.001), uIP-10 (p = 0.042), and uGalectin-9 (p = 0.009) were significantly increased in patients with active renal SLE compared to active renal AAV. sGalectin-9 (p < 0.001) and sIP-10 levels (p = 0.06) were decreased after 8 (5–22.5) months of treatment.Conclusion: sIP-10, uIP-10, sGalectin-9, and uSIGLEC-1 reflect global disease activity in SLE but do not outperform C3 and C4. sIP-10 and uIP-10 may be specific for active SLE compared to active AAV. sIP-10 and sGalectin-9 might be valuable in monitoring response after treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, İstanbul Faculty of Medicine, İstanbul University, Turkiye.
- Graduate School of Health Sciences, İstanbul University, İstanbul, Turkiye.
- Department of Immunology, Aziz Sancar Institute of Experimental Medicine, İstanbul University, İstanbul, Turkiye.
- Division of Nephrology, School of Medicine, Bezmialem Vakıf University, İstanbul, Turkiye.
- Department of Pathology, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkiye.
- Division of Nephrology, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkiye.
ORCID-Profile: Şafak Mirioğlu, Suzan Çinar, Ömer Uludağ, Erdem Gürel, Sibel Varelci, Yasemin Özlük, Işın Kiliçaslan, Yasemin Yalçinkaya, Halil Yazici, Ahmet Gül, Murat Inanç, Bahar Artim Esen
Zitieren
APA
Mirioğlu, Ş., Çinar, S., Uludağ, Ö., Gürel, E., Varelci, S., Özlük, Y., Kiliçaslan, I., Yalçinkaya, Y., Yazici, H., Gül, A., Inanç, M., & Artim Esen, B. (2024). Serum and urine interferon-inducible protein 10, galectin-9, and SIGLEC-1 as biomarkers of disease activity in systemic lupus erythematosus. Turkish Journal of Medical Sciences, 54(2), 391-400. https://doi.org/10.55730/1300-0144.5804
Vancouver
Mirioğlu Ş, Çinar S, Uludağ Ö, Gürel E, Varelci S, Özlük Y, et al. Serum and urine interferon-inducible protein 10, galectin-9, and SIGLEC-1 as biomarkers of disease activity in systemic lupus erythematosus. Turkish Journal of Medical Sciences. 2024;54(2):391-400. doi:10.55730/1300-0144.5804
BibTeX
@article{Miriolu2024,
author = {Mirioğlu, Şafak and Çinar, Suzan and Uludağ, Ömer and Gürel, Erdem and Varelci, Sibel and Özlük, Yasemin and Kiliçaslan, Işın and Yalçinkaya, Yasemin and Yazici, Halil and Gül, Ahmet and Inanç, Murat and Artim Esen, Bahar},
title = {Serum and urine interferon-inducible protein 10, galectin-9, and SIGLEC-1 as biomarkers of disease activity in systemic lupus erythematosus},
journal = {Turkish Journal of Medical Sciences},
year = {2024},
volume = {54},
number = {2},
pages = {391--400},
doi = {10.55730/1300-0144.5804}
}
EUVIMED